Fewer and fewer stocks look promising these days when the markets take wild swings and punish most companies under the sun. Has the investing community taken down some solid stocks? According to the chart and numbers available for TMO, I am inclined to favor a long position in the stock.
Thermo Fisher Scientific, Inc. (TMO) provides analytical instruments, equipment, software, and services for research, manufacture, analysis, discovery, and diagnostics in the pharmaceutical markets.
Increased mutual fund interest, reasonable P/E at 12, good volume (just under 5 million/day), low debt, and high ranking in the sector make this company worth considering. TMO is trading today at 37.41, this may be a good entry point.